Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 90.14%263.78B | 60.27%779.71B | 37.01%138.73B | -13.15%486.51B | -7.89%135.76B | -3.45%133.23B | -16.28%116.26B | -25.52%101.25B | 34.37%560.19B | 26.16%147.39B |
| Cost of revenue | 49.04%92.14B | 39.15%334.62B | 22.90%61.82B | -0.27%240.48B | -3.73%66.13B | 16.77%65.85B | -1.39%58.2B | -11.79%50.3B | 33.23%241.13B | 35.94%68.69B |
| Gross profit | 123.18%171.64B | 80.91%445.09B | 50.94%76.91B | -22.89%246.03B | -11.52%69.63B | -17.42%67.39B | -27.28%58.06B | -35.44%50.95B | 35.25%319.06B | 18.69%78.7B |
| Operating expense | 4.62%47.69B | 31.95%216.92B | 24.26%45.58B | 8.61%164.4B | 24.79%50.11B | 0.44%40.56B | 0.95%37.06B | 7.46%36.68B | 24.92%151.37B | 23.12%40.15B |
| Selling and administrative expenses | 10.92%50.51B | 22.92%195.39B | 23.41%45.54B | 4.55%158.96B | 1.72%41.19B | 0.20%40.61B | 8.82%40.26B | 8.46%36.9B | 25.52%152.04B | 23.98%40.49B |
| -General and administrative expense | 10.92%50.51B | 22.92%195.39B | 23.41%45.54B | 4.55%158.96B | 1.72%41.19B | 0.20%40.61B | 8.82%40.26B | 8.46%36.9B | 25.52%152.04B | 23.98%40.49B |
| Other operating expenses | -25.13%143M | 144.51%22.9B | 80.19%191M | 2,695.52%9.37B | 12,383.56%9.11B | -18.92%60M | 405.88%86M | -38.01%106M | -48.22%335M | 82.50%73M |
| Total other operating income | 1,854.61%2.97B | -65.21%1.37B | -53.52%152M | 291.43%3.93B | -52.66%196M | -48.88%114M | 971.34%3.29B | 454.24%327M | 65.51%1B | 360.00%414M |
| Operating profit | 295.70%123.95B | 179.51%228.16B | 119.53%31.33B | -51.32%81.63B | -49.34%19.53B | -34.92%26.83B | -51.31%21B | -68.14%14.27B | 46.15%167.69B | 14.41%38.55B |
| Net non-operating interest income (expenses) | -528.93%-2.6B | 2.05%-3.39B | 146.25%605M | -196.51%-3.46B | -585.93%-926M | 83.95%-580M | -117.41%-644M | -136.00%-1.31B | 122.68%3.58B | -110.26%-135M |
| Non-operating interest income | -45.90%693M | 52.33%1.9B | 335.71%1.28B | -72.10%1.24B | 360.98%378M | 126.76%322M | -93.58%252M | -92.64%294M | 133.16%4.46B | -94.50%82M |
| Non-operating interest expense | 386.39%3.29B | 12.34%5.28B | -57.80%676M | 437.37%4.7B | 500.92%1.3B | -75.98%902M | 294.71%896M | 346.24%1.6B | 188.78%875M | 24.71%217M |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | ||||||||||
| Other non-operating income (expenses) | ||||||||||
| Income before tax | 280.07%121.36B | 187.55%224.77B | 146.35%31.93B | -54.36%78.17B | -51.57%18.6B | -30.21%26.25B | -56.53%20.36B | -73.23%12.96B | 47.21%171.27B | 9.72%38.41B |
| Income tax | 286.96%31.18B | 300.48%63.6B | 114.34%8.06B | -61.15%15.88B | -55.79%3.46B | -43.73%5.05B | -70.24%3.62B | -68.46%3.76B | 40.73%40.87B | -9.09%7.82B |
| Net income | 277.75%90.18B | 158.75%161.18B | 159.43%23.87B | -52.23%62.29B | -50.49%15.15B | -25.97%21.21B | -51.72%16.74B | -74.79%9.2B | 49.37%130.4B | 15.85%30.59B |
| Net income continuous operations | 277.75%90.18B | 158.75%161.18B | 159.43%23.87B | -52.23%62.29B | -50.49%15.15B | -25.97%21.21B | -51.72%16.74B | -74.79%9.2B | 49.37%130.4B | 15.85%30.59B |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 277.75%90.18B | 158.75%161.18B | 159.43%23.87B | -52.23%62.29B | -50.49%15.15B | -25.97%21.21B | -51.72%16.74B | -74.79%9.2B | 49.37%130.4B | 15.85%30.59B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 277.75%90.18B | 158.75%161.18B | 159.43%23.87B | -52.23%62.29B | -50.49%15.15B | -25.97%21.21B | -51.72%16.74B | -74.79%9.2B | 49.37%130.4B | 15.85%30.59B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 280.65%123.14 | 158.93%218.67 | 159.06%32.35 | -51.56%84.45 | -50.67%20.52 | -25.79%28.74 | -50.49%22.69 | -74.00%12.4875 | 55.13%174.35 | 20.63%41.6 |
| Diluted earnings per share | 280.78%122.8 | 159.04%218.01 | 159.24%32.25 | -51.54%84.16 | -50.64%20.45 | -25.75%28.66 | -50.49%22.62 | -73.99%12.44 | 55.33%173.68 | 20.76%41.43 |
| Dividend per share | 0 | 13.87%39 | 0 | 1.48%34.25 | 2.86%18 | 0 | 0.00%16.25 | 0 | 12.50%33.75 | 0.00%17.5 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |